Cagrilintide
Cagrilintide
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Cagrilintide Overview
Cagrilintide is a synthetic, long-acting analog of the naturally occurring peptide amylin. It is studied in laboratory and preclinical models for its ability to activate target receptor pathways, contributing to the characterization of endocrine and neuroendocrine signaling. Research has examined its role in modulating downstream signaling cascades, receptor binding kinetics, and systemic pathway dynamics.
History
Research into amylin biology began in the late 20th century with its identification as a pancreatic peptide co-secreted with insulin. Native amylin was found to activate specific receptor pathways but was limited by rapid degradation. Cagrilintide was later developed as a stabilized analog with prolonged target activity, providing a research tool for studying calcitonin receptor family signaling and endocrine cross-talk in experimental systems.
Cagrilintide Structure
Molecular Formula: C₂₉₄H₄₆₆N₈₄O₈₈S₂
Molecular Weight: 6781.6 g/mol
PubChem ID: 137465331
Research Findings
Cagrilintide has been studied in endocrine, signaling, and systemic models, with research highlighting its role in receptor binding pharmacology, downstream cascades, and pathway characterization. Studies also report activity in amylin receptor signaling, endocrine markers, and signaling homeostasis in preclinical and experimental settings.
Key Areas of Research::
-
Signaling: Receptor binding, cascades, dynamics
-
Endocrine: Amylin pathways, downstream markers
-
Systemic: Signaling homeostasis, resilience, viability
Together, these findings suggest broad experimental potential for Cagrilintide across signaling, endocrine, and systemic pathways. By engaging amylin receptor biology and influencing downstream signaling cascades, Cagrilintide provides a versatile platform for research into receptor pharmacology, pathway characterization, and systemic dynamics in laboratory settings.